Eugene de Juan Jr., M.D.

Distinguished Professor of Ophthalmology, University of California, San Francisco

Managing Partner, ForSight Labs

Ophthalmology, Drug Delivery, Early Stage Company Development

EDUCATION

BS – Emory University

MS – University of Alabama in Birmingham

MD – University of South Alabama

AWARDS AND ACCOLADES

Lifetime Achievement Award. American Academy of Ophthalmology

Industry Innovator of the Year Award (OIS)

Catalyst Award, Glaucoma Research Foundation

Heed-Gutman Award, The Society of Heed Fellows

COMPANIES AND BOARDS

Co-Founder:  Azura, Second Sight (NASDAQ:EYES), InnoRx (acquired by Surmodics), NeoVista (acquired by Orya), Retina Lab (acquired by Iridex), Transcend Medical (acquired by Novartis), ForSight VISION 1- 6: ForSight VISION 2 (acquired by QLT), ForSight VISION 4 acquired by Genentech/Roche), ForSight VISION5 (acquired by Allergan)

Board of Directors:  Sprial Therapuetics, ForSight Vision 6, Presby, Voyant, Nexis Vision, Inc. (formerly ForSight VISION3)

MEMBER OF Investment Committee

Associated Portfolio Companies

Recognify Life Sciences
Boost Neuroscience